Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
Article in Biotechnology Letters (January 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients
Article in Frontiers in Immunology (February 2021)
Immunotherapy of gastric cancer: Past, future perspective and challenges
Article in Pathology - Research and Practice (December 2020)